Cardiology Module

Risk calculators

Seven validated clinical risk calculators with plain-language narratives:

SCORE2 / SCORE2-OP (ESC 2021) — 10-year CVD risk, treatment threshold

GRACE 2.0 (ACC/AHA) — 6-month mortality after ACS

TIMI STEMI (Antman 2000) — 30-day mortality in STEMI

TIMI NSTEMI/UA (Antman 2000) — 14-day MACE risk

CHA2DS2-VASc (ESC 2020) — Stroke risk in AF, anticoagulation decision

HAS-BLED (ESC 2020) — Bleeding risk on anticoagulation

HEART Score (Six 2010) — MACE risk in chest pain presentation

All input fields are pre-filled from the patient latest vitals and chronic conditions. The narrative output references the relevant ESC or ACC/AHA guideline section.

Cardiac studies

Attach and organise results for:

ECG — upload PDF or image; mark intervals (PR, QRS, QTc) manually

Echocardiogram — structured fields: EF, LV dimensions, wall motion, valvular findings

Holter — 24/48/72 hour; arrhythmia summary

Stress ECG — protocol, METs achieved, ST changes, symptoms

Nuclear/MRI/CT — file upload and free text

All studies are listed in the Cardiac Studies timeline, sortable by date and type. Previous studies are visible during sessions for comparison.

Device registry

Track implanted cardiac devices:

Pacemaker — Model, serial number, lead details, date implanted, programmer settings

ICD — Model, serial number, therapy zones, shock history

CRT-D / CRT-P — Biventricular settings, LV lead position

Loop Recorder — Model, date inserted, extraction date

Device check appointments are tracked with a history of each interrogation result. Manufacturer recall alerts can be recorded against device serial numbers.

GDMT heart failure tracker

The GDMT tracker ensures patients with HFrEF are on all four pillars of guideline-directed medical therapy:

ACEi / ARB / ARNI — target: Sacubitril/Valsartan 97/103mg BD

Beta-blocker — target: Carvedilol 25mg BD

MRA — target: Eplerenone 50mg OD

SGLT2i — target: Dapagliflozin 10mg OD

Current doses are pulled from the patient active medication list. The checklist highlights gaps and contraindications.